Fulgent Genetics (7F0) Ownership - Who Owns Fulgent Genetics?
Fulgent Genetics (7F0) Ownership Overview
- 40.01% Insiders
- 14.98% Mutual Funds
- 1.23% Other Institutional Investors
- 10.45% ETFs
- 33.33% Public Companies and Individual Investors
The ownership structure of Fulgent Genetics (DE:7F0) stock is a mix of institutional, retail, and individual investors. Approximately 26.66% of the company’s stock is owned by Institutional Investors, 40.01% is owned by Insiders, and 33.33% is owned by Public Companies and Individual Investors.
The ownership structure of Fulgent Genetics (DE:7F0) stock is a mix of institutional, retail, and individual investors. Approximately 26.66% of the company’s stock is owned by Institutional Investors, 40.01% is owned by Insiders, and 33.33% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 02, 2026 | Jian Xie | $41,796 | |
| Sep 02, 2026 | Hanlin Gao | $32,874 | |
| Aug 27, 2026 | Jian Xie | $23,741 | |
| Aug 27, 2026 | Hanlin Gao | $18,686 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Entrypoint Capital, Llc | €200,676 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ming Hsieh | 9,003,883 | Insider | 32.72% | 192,061,828 |
| BlackRock, Inc. | 2,286,669 | Institution | 8.31% | 48,776,936 |
| Hanlin Gao | 984,472 | Insider | 3.58% | 20,999,772 |
| Vanguard | 925,081 | Institution | 3.36% | 19,732,903 |
| Ishares | 793,038 | Institution | 2.88% | 16,916,294 |
| Vanguard Index Funds | 769,411 | Institution | 2.80% | 16,412,306 |
| Jian Xie | 576,379 | Insider | 2.09% | 12,294,740 |
| Columbia Funds Series Trust I | 490,589 | Institution | 1.78% | 10,464,754 |
| Northern Lights Fund Trust Ii | 464,244 | Institution | 1.69% | 9,902,789 |
| Dfa | 370,038 | Institution | 1.34% | 7,893,281 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 769,411 | Institution | 2.80% | 16,412,306 |
| Columbia Funds Series Trust I | 490,589 | Institution | 1.78% | 10,464,754 |
| Northern Lights Fund Trust Ii | 464,244 | Institution | 1.69% | 9,902,789 |
| Columbia Funds Series Trust I | 347,079 | Institution | 1.26% | 7,403,542 |
| Dfa Investment Dimensions Group Inc | 325,844 | Institution | 1.18% | 6,950,578 |
| Blackrock Funds | 301,024 | Institution | 1.09% | 6,421,143 |
| Fidelity Salem Street Trust | 243,261 | Institution | 0.88% | 5,189,000 |
| Fidelity Concord Street Trust | 203,039 | Institution | 0.74% | 4,331,025 |
| Vanguard Scottsdale Funds | 130,320 | Institution | 0.47% | 2,779,856 |
| Schwab Capital Trust | 120,244 | Institution | 0.44% | 2,564,925 |
FAQ
Who Owns Fulgent Genetics (DE:7F0)?
According to the latest TipRanks data, approximately 26.66% of the company's stock is held by institutional investors, 40.01% is held by insiders, and 33.33% is held by public companies and individual investors.
What percentage of Fulgent Genetics (DE:7F0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 26.66% of Fulgent Genetics (DE:7F0) stock is held by institutional investors: 14.98% by mutual funds, 10.45% by ETFs and 1.23% by other institutional investors.
What percentage of Fulgent Genetics (DE:7F0) stock is held by retail investors?
According to the latest TipRanks data, approximately 33.33% of Fulgent Genetics (DE:7F0) stock is held by public companies and individual investors.
Who owns the most shares of Fulgent Genetics (DE:7F0)?
Ming Hsieh owns the most shares of Fulgent Genetics (DE:7F0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
